Boothbay Fund Management’s Jasper Therapeutics JSPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-13,853
| Closed | -$296K | – | 1418 |
|
|
2024
Q4 | $296K | Buy |
13,853
+1,617
| +13% | +$34.6K | 0.01% | 920 |
|
|
2024
Q3 | $230K | Sell |
12,236
-11,088
| -48% | -$209K | 0.01% | 1172 |
|
|
2024
Q2 | $529K | Hold |
23,324
| – | – | 0.01% | 846 |
|
|
2024
Q1 | $685K | Buy |
+23,324
| New | +$685K | 0.01% | 766 |
|
|
2023
Q4 | – | Sell |
-23,316
| Closed | -$163K | – | 1638 |
|
|
2023
Q3 | $163K | Hold |
23,316
| – | – | ﹤0.01% | 1273 |
|
|
2023
Q2 | $319K | Sell |
23,316
-25
| -0.1% | -$342 | 0.01% | 1073 |
|
|
2023
Q1 | $422K | Buy |
+23,341
| New | +$422K | 0.01% | 1115 |
|
|
2020
Q3 | – | Sell |
-6,060
| Closed | -$614K | – | 1019 |
|
|
2020
Q2 | $614K | Buy |
+6,060
| New | +$614K | 0.04% | 441 |
|